Prelude Therapeutics
PRLD
PRLD
60 hedge funds and large institutions have $188M invested in Prelude Therapeutics in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
Holders
60
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$518K | |
| 2 | +$481K | |
| 3 | +$328K | |
| 4 |
Citigroup
New York
|
+$311K |
| 5 |
6CM
683 Capital Management
New York
|
+$173K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$531K | |
| 3 | -$403K | |
| 4 |
BlackRock
New York
|
-$396K |
| 5 |
Two Sigma Investments
New York
|
-$324K |